- Home
- Member Resources
- Articles
-
Five different ways to get involved at the College of American Pathologists as a member who is not on a committee
-
The CAP was invited by Rep. Robin Kelly (D-IL), co-chair of the Congressional Black Caucus (CBC) Health Braintrust, to discuss the CAP's top health equity and disparities priorities for the 118th Congress.
-
The College of American Pathologists (CAP) launched the Council of Informatics and Pathology Innovation (CIPI), its first new council in 18 years.
-
Diagnosis and classification of acute myeloid leukemia (AML) have significantly changed in 2022 with the newly proposed WHO 5th edition and International Consensus Classification (ICC) classification of hematopoietic neoplasms (subsequently referred to as WHO 2022 and ICC 2022 classification, respectively).
-
Dr. Mary Fowkes passed away suddenly in late 2020, but her autopsies of early COVID victims yielded insights that made a lasting impact on treatment protocols for COVID-19.
-
Learn more about the 13 new digital pathology add-on codes intended to capture and report additional clinical staff work and service requirements associated with digitizing glass microscope slides for primary diagnosis.
-
Casey Schukow, DO shares his experience with navigating a transitional year residency and gives advice on making the most of this time.
-
This article highlights the CAP's efforts to promote and advance diversity in clinical trials, a critical area of medicine that often fails to represent and serve minorities.
-
Dr. Nicole Riddle explains why it is essential to have diversification and improved inclusivity on your teams, committees, and leadership groups.
-
As the physicians who lead blood bank operations, pathologists serve as translators between the blood bank and patient-care teams, especially as blood shortages become more frequent.
-
The diagnosis of a neurodegenerative disease (NDD) based on physical examination findings and clinical symptoms is often challenging. Recent studies have shown over 30% of patients are misdiagnosed early in the disease process due to non-specific clinical findings. An update on emerging biomarker testing within the field of neurodegenerative changes is provided here to educate pathologists on these new developments.
-
If you are looking to get more involved with the College of American Pathologists (CAP) in the new year, consider applying for a committee. Through their respective responsibilities, committees directly impact the CAP, its members, and pathology. With over 60 committees to choose from, you can apply for one that matches your skills, interests, and professional goals.
-
Members of the Digital Content Committee hosted a Reddit AMA, answering questions about pathology residency applications, how to match into pathology, and the best way to learn more about the specialty of pathology.
-
Stay up-to-date on your curriculum vitae (CV), upcoming CME requirements, personal records, and licensure status. As a new-in-practice pathologist, this may be a new routine you need to establish. Here are some tips on how to keep up with the extras.
-
Members of the Digital Content Committee hosted a Reddit AMA. Here are some of the questions and answers about matching into a pathology residency and the best way to learn more about the specialty of pathology while in medical school.
-
Members of the Digital Content Committee answered questions about pathology residency applications, how to match into pathology, and the best way to learn more about the specialty of pathology.
-
Members of the Digital Content Committee answered questions about matching into a pathology residency and the best way to learn more about the specialty of pathology while in medical school.
-
CAP member Dr. Nicole Riddle delves into Imposter Syndrome and the detrimental effects these negative beliefs can have on your professional and personal lives, not to mention your mental well-being.
-
Chimeric antigen receptor (CAR) T-cell therapy is one of the most promising approaches in anticancer therapy and an exponential number of pre-clinical and clinical studies are being carried out every year to expand its use. CAR T-cell therapy represents a cellular immunotherapy where T-cells are redirected against the tumor after engineered expression of CARs. CARs are receptor proteins that have been designed to give T-cells the new ability to target a specific antigen. The process involves taking T-cells from blood, editing the T-cells to express a CAR to recognize a specific antigen on the targeted cell (e.g., CD19 on B-cells or CD38 on plasma cells), growing those cells in the laboratory, and then administering them to the patient to bind to cancer cells and eliminate them.
-
Succession planning should be based on a well-thought-out strategy to identify, recruit, and develop leaders at all levels of an organization. This article shares eight succession planning best practices, specifically catered to medical groups.